Arthur Taveras X4 Pharmaceuticals, Inc (XFOR) insider trading activity

Arthur Taveras is Chief Scientific Officer of X4 Pharmaceuticals, Inc. Currently has a direct ownership of 234,301 shares of XFOR, which is worth approximately $154,638. The most recent transaction as insider was on Mar 11, 2024, when has been sold 14,235 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $12,526. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 234K

0% 3M change

171.27% 12M change

Total Value Held $154,638

Arthur Taveras Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2024	SELL Open market or private sale	$12,526 $0.88 p/Share	14,235 Reduced 5.73%	234,301 Common Stock
Feb 12 2024	SELL Open market or private sale	$794 $1.01 p/Share	787 Reduced 0.32%	248,536 Common Stock
Nov 01 2023	SELL Open market or private sale	$49,417 $0.73 p/Share	67,695 Reduced 21.35%	249,323 Common Stock
Oct 31 2023	BUY Grant, award, or other acquisition	-	230,645 Added 42.11%	317,018 Common Stock
Mar 10 2023	SELL Open market or private sale	$14,117 $0.84 p/Share	16,806 Reduced 16.29%	86,373 Common Stock
Feb 13 2023	SELL Open market or private sale	$863 $0.93 p/Share	928 Reduced 0.89%	103,179 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	97,000 Added 48.23%	104,107 Common Stock
Feb 11 2022	SELL Payment of exercise price or tax liability	-	928 Reduced 11.55%	7,107 Common Stock
Mar 24 2021	BUY Grant, award, or other acquisition	-	8,035 Added 50.0%	8,035 Common Stock

Arthur Taveras

Chief Scientific Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XFOR shares.

Notify only if

Value

Insider Trading

Get notified when an X4 Pharmaceuticals, Inc insider buys or sells XFOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to X4 Pharmaceuticals, Inc

Track Activities on XFOR

Account